Health Catalyst, Inc. (HCAT) News
Follow Health Catalyst, Inc. (HCAT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 21 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Health Catalyst Reports Q3 2026 Revenue of $56.3 Million
Revenue exceeded the high end of prior guidance. Net income was $40.5 million, or $0.53 per share, including a $65.9 million gain from the Vitalware sale; adjusted loss was $0.03 per share. Health Catalyst reaffirmed ful
EQUITY | Nov 06, 2026, 02:05 PM UTC
L
Health Catalyst 3Q 2026: Revenue $56.28M, EPS $0.53 — 10-Q Summary
Health Catalyst's revenue declined year over year as the Vitalware divestiture, DOS-to-Ignite migration churn and downselling, and exits from lower-margin TEMS arrangements weighed on results. Earnings swung to income, l
EARNINGS | Nov 05, 2026, 10:22 PM UTC
L
Health Catalyst 3Q EPS 53c >HCAT
Health Catalyst 3Q EPS 53c >HCAT
EARNINGS | Nov 05, 2026, 09:09 PM UTC
M
Health Catalyst Reports Third-Quarter 2026 Results
Health Catalyst reported financial results for the quarter ended September 30, 2026.
EQUITY | Nov 05, 2026, 09:09 PM UTC
L
Health Catalyst 3Q Rev $56.3M >HCAT
Health Catalyst 3Q Rev $56.3M >HCAT
EQUITY | Nov 05, 2026, 09:03 PM UTC
L
Health Catalyst 3Q Net $40.5M >HCAT
Health Catalyst 3Q Net $40.5M >HCAT
EQUITY | Nov 05, 2026, 09:03 PM UTC
H
Health Catalyst Reports Q2 2026 Results: Full Earnings Call Transcript
Health Catalyst (NASDAQ: HCAT ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data.
LIVE | Sep 18, 2026, 10:47 AM UTC
L
HCAT - Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
HCAT - Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
NEWS | Sep 14, 2026, 10:32 PM UTC
L
Tami Reller Joins Health Catalyst Board as Audit Committee Chair
Health Catalyst appointed Tami Reller to its board effective October 1, 2026, naming her Audit Committee chair and a member of the Compensation Committee.Original SEC Filing: Health Catalyst, Inc. [ HCAT ] - 8-K - Sep. 1
REGULATION | Sep 14, 2026, 08:47 PM UTC
L
Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
Reller Joins Health Catalyst as it Enters Its Next Phase of GrowthSALT LAKE CITY, Sept. 14, 2026 // -- Health Catalyst, Inc. ("Health Catalyst", NASDAQ:HCAT), a healthcare intelligence company designed to accelerate meas
NEWS | Sep 14, 2026, 08:20 PM UTC
L
HCAT - Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
HCAT - Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
NEWS | Sep 14, 2026, 08:20 PM UTC
L
Health Catalyst appoints Simeon Kohl as CEO effective Sept. 14
Health Catalyst named Simeon Kohl as chief executive officer, president and a member of its board. The appointment takes effect Sept. 14, succeeding Ben Albert as CEO.
EQUITY | Sep 08, 2026, 12:49 PM UTC
M
Health Catalyst appoints Simeon Kohl CEO and President effective Sept. 14
Health Catalyst appointed Simeon Kohl as Chief Executive Officer, President and director effective September 14, 2026. Ben Albert transitioned to Chief Business Officer effective September 14, 2026, and resigned as CEO e
REGULATION | Sep 08, 2026, 12:23 PM UTC
L
Health Catalyst names Simeon Kohl CEO and President
Health Catalyst appointed Simeon Kohl as Chief Executive Officer and President. Ben Albert will continue as Chief Business Officer.
EQUITY | Sep 08, 2026, 12:07 PM UTC
L
HCAT - Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
HCAT - Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
GEOPOLITICS | Sep 08, 2026, 12:06 PM UTC
L
Health Catalyst adds Simeon Koh to board effective Sept 14
Simeon Koh has been appointed a member of Health Catalyst’s board of directors, effective Sept 14.
EQUITY | Sep 08, 2026, 12:05 PM UTC
L
Health Catalyst appoints Simeon Kohl as CEO
Health Catalyst appointed Simeon Kohl as CEO, replacing the prior leadership.
EQUITY | Sep 08, 2026, 12:05 PM UTC
L
Health Catalyst to participate in upcoming investor conference
Health Catalyst said it will participate in an upcoming investor conference.
EQUITY | Aug 31, 2026, 08:07 PM UTC
L
HCAT - Health Catalyst to Participate in Upcoming Investor Conference
HCAT - Health Catalyst to Participate in Upcoming Investor Conference
EQUITY | Aug 31, 2026, 08:06 PM UTC
L
Citigroup Maintains Neutral on Health Catalyst, Lowers Price Target to $2
Citigroup analyst Daniel Grosslight maintains Health Catalyst (NASDAQ: HCAT ) with a Neutral and lowers the price target from $2.5 to $2.
EQUITY | Aug 11, 2026, 08:07 PM UTC
H
Why Atlassian Shares Are Trading Higher By More Than 30%; Here Are 20 Stocks Moving Premarket
Shares of Atlassian Corp (NASDAQ: TEAM ) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results. Atlassian reported fourth-quarter revenue of $1.766 billion, u
EARNINGS | Aug 07, 2026, 08:33 AM UTC